Senzime communicates strategic and financial goals
Press release: Uppsala, September 23, 2020. Senzime AB (publ) today announces the company’s strategic and financial goals for 2023. Senzime develops and markets digital patient monitoring systems to prevent complications during and after anesthesia. Senzime's TetraGraph system is currently CE marked, FDA cleared, and market approved, in additional countries such as Japan, South Korea and Australia. Since its launch in 2019, Senzime has delivered approximately 600 systems to hospitals worldwide. Despite limited access to hospitals during the COVID-19 pandemic, Senzime has had